Development Of Novel Liposome-Encapsulated Combretastatin A4 Acylated Derivatives: Prodrug Approach For Improving Antitumor Efficacy
Yongwei Gu,1,2,* Juanjuan Ma,2,* Zhiqin Fu,1,2,* Youfa Xu,1,2 Baoan Gao,1,2 Jianzhong Yao,3 Wei Xu,1 Kedan Chu,1 Jianming Chen1,2 1Department of Pharmacy, Fujian University of Traditional Chinese Medicine, Fujian 350108, People’s Republic of China; 2Shanghai Wei Er Biopharmaceutical Techno...
Guardado en:
Autores principales: | Gu Y, Ma J, Fu Z, Xu Y, Gao B, Yao J, Xu W, Chu K, Chen J |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Dove Medical Press
2019
|
Materias: | |
Acceso en línea: | https://doaj.org/article/2ba372d11fee4e76b49c1d7ac1b92aa4 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Liver-targeted liposomes for codelivery of curcumin and combretastatin A4 phosphate: preparation, characterization, and antitumor effects
por: Jiang H, et al.
Publicado: (2019) -
Encapsulation of α-Pinene in Delivery Systems Based on Liposomes and Cyclodextrins
por: Zahraa Hammoud, et al.
Publicado: (2021) -
Smart Hydrogels – Synthetic Stimuli-Responsive Antitumor Drug Release Systems
por: Kasiński A, et al.
Publicado: (2020) -
NIR responsive liposomal system for rapid release of drugs in cancer therapy
por: Chen MM, et al.
Publicado: (2017) -
Electrospun Amphiphilic Nanofibers as Templates for In Situ Preparation of Chloramphenicol-Loaded Liposomes
por: Ivo Laidmäe, et al.
Publicado: (2021)